Poliomyelitis leading to large-scale trials in the then Belgian Congo and the vaccination of seven million children in Poland against serotypes PV1 and PV3 between 1958 and 1960. The second inactivated polio virus vaccine was developed in 1952 by Jonas Salk at the University of Pittsburgh, and announced to the world on 12 April 1955. The Salk vaccine, or inactivated poliovirus vaccine, is based on poliovirus grown in a type of monkey kidney tissue culture (vero cell line), which is chemically inactivated with formalin. After two doses of inactivated poliovirus vaccine (given by injection), 90 percent or more of individuals develop
Salk Hall Roosevelt's Public Works Administration. The 225-bed hospital was originally part of the Medical Center associated with the University and was intended to be used primarily to treat communicable diseases. However, when antibiotics virtually eliminated the need to quarantine patients, the building had become a financial burden on the city. Therefore, in September 1949, work began on remodeling the building, and it temporarily housed Pitt's School of Public Health. In October 1957, the Municipal Hospital was formally acquired from the city for $1.3 million ($ million today) and renamed Jonas Salk Hall. For a time, the upper floors of the building